The experience and perception of wearable devices in Parkinson’s disease patients: a systematic review and meta-synthesis of qualitative studies DOI Creative Commons

Yanjie Ma,

Yifan Zhang, Rui Li

et al.

Journal of Neurology, Journal Year: 2025, Volume and Issue: 272(5)

Published: April 19, 2025

Parkinson's disease (PD) is the fastest-growing neurodegenerative disorder, affecting over 8.5 million people worldwide, with symptoms that severely impact patients' quality of life. While treatments like levodopa and deep brain stimulation help manage symptoms, they require frequent adjustments have limitations. Wearable devices offer real-time monitoring motor non-motor enabling personalized treatment, but challenges related to comfort, usability, patient adherence hinder their widespread adoption. Many individuals PD experience discomfort, emotional distress, or interface difficulties, reducing long-term adherence. This study synthesizes qualitative research on experiences wearables identify key usability barriers improve device design for better clinical integration. Following Joanna Briggs Institute methodology systematic reviews, we searched PubMed, Web Science, Embase, Cochrane Library, CINAHL, CNKI, WanFang, VIP databases up March 3, 2025. Additional gray literature reference lists were examined manually. Included studies underwent comprehensive assessment, integration, analysis. Nine included, identifying four main themes eleven sub-themes. The primary physiological experience, psychological Responses, social Interaction, Expectation. meta-synthesis reveals dual role wearable in managing disease, improving autonomy control while presenting reliability, well-being. findings emphasize need personalized, context-sensitive adapt fluctuating address privacy concerns, seamlessly integrate into practice outcomes

Language: Английский

Editorial: Effectiveness of exercise and diet on movement disorders DOI Creative Commons
Adérito Seixas, Cláudia Silva, Mário Bernardo-Filho

et al.

Frontiers in Aging Neuroscience, Journal Year: 2025, Volume and Issue: 17

Published: Feb. 20, 2025

Movement disorders (MD) are complex neurological conditions affecting the amount and fluidity of available movement control. These have multiple possible causes do not fit into other established diagnostic categories. MD, which include such as Parkinson's disease (PD), system atrophy (MSA), progressive supranuclear palsy (PSP), corticobasal syndrome, cervical dystonia others, a significant impact on quality life individuals worldwide but prevalence incidence rates vary by condition geographical area (Abbas et al., 2018).The MD increase with age (Wenning 2005), essential tremor PD being more common (Luo 2025;Song 2021). The spectrum impairments is very broad, bradykinesia or hypokinesia at one end tremor, dystonia, chorea, stereotypies, athetosis, myoclonus dyskinesias (Jankovic & Lang, In hyperkinetic disorders, abnormal involuntary movements may occur rest during voluntary be rhythmic (e.g. tremor), sustained dystonia) irregular chorea myoclonus) (Arabia 2022;Novellino 2009;Perju-Dumbrava Kempster, 2020;Stephen 2023). On hand, hypokinetic characterized reduction in and/or difficulty initiating often no identifiable cause referred to primary opposed secondary causes, infection (Desai 2024;Divya 2024). Both groups present both motor non-motor symptoms present, diagnosis management these challenging task for healthcare professionals, especially knowing that criteria frameworks diverse (Mestre 2023).For complete assessment, historical -family personal, including birth history early developmental abnormalities -and clinical features obtained physical examination laboratory testing paramount importance addition, technologysuch apps wearables -has shown promising results increasing objectivity assessment (Caroppo 2025;Vanmechelen 2023;Willemse 2024) proper validation studies needed confidence clinicians implementing solutions practice.The people also challenging, they experience difficulties mobility, balance activities daily living, symptoms, cognitive changes psychiatric manifest progresses. Given nature conditions, palliative approach can help throughout course long-term (Miyasaki 2022). Pharmacological therapy cornerstone (Jankovic, 2009;Pirker 2023) approaches, gene Kim Chang, 2024), becoming increasingly relevant. Moreover, evidence highlights therapeutic potential non-pharmacological approaches exercise therapy, nutrition-based interventions, reduce progression severity (Ferrazzoli 2022;Lister, 2020;Macías-García 2024;Zhang 2024).The aim this Research Topic was share ideas, opinions, comments latest research providing mechanisms safety exercise-and diet-induced neuroprotective, anti-inflammatory immunological) strategies improve adherence empowerment different contexts, gaps still need filled high evidence. This includes eight papers address questions. Four original four literature reviews deepen our understanding interventions their practical applications. Among contributions, Mateus Caldas reported three cases palsy, describing benefits physiotherapy through improving functionality life; cross-sectional study strengthened knowledge association between function health-related (Ge al.), insights aspects should tackled professionals; Yaqoob al. demonstrated an accelerometer-based gait sit-to-stand tasks has good agreement direct observation; Taloria presented non-randomized demonstrating multimodal (exercise, speech cognitive) training programme PD.The systematic published provided valuable certainty existing guide working well future area. Homann showed randomised controlled trials analysing Vitamin D supplementation later show benefit limited number MD. However, mainly led authors conclude there clear further For robust provide researchers. Yuan network meta-analysis identifying specific modalities dosages significantly patients PD, aquatic emerging most effective modality. findings partially challenged Liu who concluded hydrotherapy had positive maintenance effect population, effects function, life. Finally, Cui highlighted ACSM recommendations when prescribing higher compliance were beneficial balance, population.Taking account contributions Topic, body diet been strengthened. less dietary interventions.As expected increase, needed. Diet key components multidisciplinary rehabilitation strategy lacking, particularly interventions. contributes growing supporting We hope will inspire inform practice affected conditions.

Language: Английский

Citations

0

Artificial intelligence-enabled detection and assessment of Parkinson’s disease using multimodal data: A survey DOI
Aite Zhao, Yongcan Liu,

Xinglin Yu

et al.

Information Fusion, Journal Year: 2025, Volume and Issue: unknown, P. 103175 - 103175

Published: April 1, 2025

Language: Английский

Citations

0

The experience and perception of wearable devices in Parkinson’s disease patients: a systematic review and meta-synthesis of qualitative studies DOI Creative Commons

Yanjie Ma,

Yifan Zhang, Rui Li

et al.

Journal of Neurology, Journal Year: 2025, Volume and Issue: 272(5)

Published: April 19, 2025

Parkinson's disease (PD) is the fastest-growing neurodegenerative disorder, affecting over 8.5 million people worldwide, with symptoms that severely impact patients' quality of life. While treatments like levodopa and deep brain stimulation help manage symptoms, they require frequent adjustments have limitations. Wearable devices offer real-time monitoring motor non-motor enabling personalized treatment, but challenges related to comfort, usability, patient adherence hinder their widespread adoption. Many individuals PD experience discomfort, emotional distress, or interface difficulties, reducing long-term adherence. This study synthesizes qualitative research on experiences wearables identify key usability barriers improve device design for better clinical integration. Following Joanna Briggs Institute methodology systematic reviews, we searched PubMed, Web Science, Embase, Cochrane Library, CINAHL, CNKI, WanFang, VIP databases up March 3, 2025. Additional gray literature reference lists were examined manually. Included studies underwent comprehensive assessment, integration, analysis. Nine included, identifying four main themes eleven sub-themes. The primary physiological experience, psychological Responses, social Interaction, Expectation. meta-synthesis reveals dual role wearable in managing disease, improving autonomy control while presenting reliability, well-being. findings emphasize need personalized, context-sensitive adapt fluctuating address privacy concerns, seamlessly integrate into practice outcomes

Language: Английский

Citations

0